ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.477,82
0,10%
Brent Oil
88,165
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aeterna Zentaris Inc (AEZS)

  7. Aeterna Zentaris Inc (AEZS) Notícias

AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEZS
DataHoraFonteTítuloCódigoCompanhia
28/03/202408:55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
27/03/202409:05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
12/03/202415:10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
26/02/202409:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
15/02/202419:50GlobeNewswire Inc.Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproNASDAQ:AEZSAeterna Zentaris Inc
15/02/202418:54Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:AEZSAeterna Zentaris Inc
15/02/202411:33Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
22/12/202318:42Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202309:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202309:50GlobeNewswire Inc.Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
09/11/202310:00GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
11/10/202309:00GlobeNewswire Inc.Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO ConferenceNASDAQ:AEZSAeterna Zentaris Inc
05/09/202309:00GlobeNewswire Inc.Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AEZSAeterna Zentaris Inc
09/08/202309:05GlobeNewswire Inc.Aeterna Zentaris Reports Second Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
13/07/202308:30GlobeNewswire Inc.Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate UpdateNASDAQ:AEZSAeterna Zentaris Inc
05/07/202309:45GlobeNewswire Inc.Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight SeriesNASDAQ:AEZSAeterna Zentaris Inc
14/06/202317:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
14/06/202317:05GlobeNewswire Inc.Aeterna Zentaris Announces Results of Virtual 2023 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
15/05/202317:05GlobeNewswire Inc.Aeterna Zentaris Announces Virtual 2023 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
11/05/202307:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AEZSAeterna Zentaris Inc
09/05/202318:00GlobeNewswire Inc.Aeterna Zentaris Reports First Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
05/04/202308:55GlobeNewswire Inc.Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT TrialNASDAQ:AEZSAeterna Zentaris Inc
23/03/202309:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:AEZSAeterna Zentaris Inc
23/03/202309:05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
16/03/202309:05GlobeNewswire Inc.Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)NASDAQ:AEZSAeterna Zentaris Inc
17/01/202310:05GlobeNewswire Inc.Aeterna Zentaris Provides Business Update and Outlines Key Upcoming MilestonesNASDAQ:AEZSAeterna Zentaris Inc
10/01/202310:05GlobeNewswire Inc.Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch EventNASDAQ:AEZSAeterna Zentaris Inc
03/11/202209:05GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2022 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
06/09/202207:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)NASDAQ:AEZSAeterna Zentaris Inc
29/08/202209:00GlobeNewswire Inc.Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin) in U.S. and Canada from Novo NordiskNASDAQ:AEZSAeterna Zentaris Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEZS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PDGR3
PDG REALT ON
BOV
LUPA3
LUPATECH ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
COGN3
COGNA ON
BOV
PRIO3
PETRORIO ON
BOV
IFCM3
Infracommerce Caxaas ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados